Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Escalier Biosciences BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11136
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Escalier Biosciences BV (Escalier Biosciences) is a biopharmaceutical company, which develops small molecule medicines for the treatment of autoimmune disorders. Its pipeline products include topical and oral RAR-related orphan receptor gamma inverse agonists. Inhibition of RAR-related orphan receptor gamma, which is a nuclear hormone receptor, demonstrably led to reduction in the production of the inflammatory cytokine IL-17, which is involved in autoimmune disorders such as psoriasis and associated co-morbidities. The therapies aimed at inhibiting RAR-related orphan receptor gamma also target psoriatic arthritis, rheumatoid arthritis, lupus, inflammatory bowel disease and multiple sclerosis, among others. The company has offices in Encinitas, California, the US. It has lead topical and oral drug candidates in late stage preclinical studies. Escalier Biosciences is headquartered in Nijmegen, the Netherlands.

Escalier Biosciences BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Escalier Biosciences BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Escalier Biosciences Raises USD19 Million in Series B Venture Financing 10
Escalier Biosciences Secures Financing 12
Escalier Biosciences Raises USD3.5 Million in Venture Financing 13
Escalier Biosciences BV – Key Competitors 14
Escalier Biosciences BV – Key Employees 15
Escalier Biosciences BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Key Facts 2
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Escalier Biosciences BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Escalier Biosciences BV, Deals By Therapy Area, 2012 to YTD 2018 8
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Escalier Biosciences Raises USD19 Million in Series B Venture Financing 10
Escalier Biosciences Secures Financing 12
Escalier Biosciences Raises USD3.5 Million in Venture Financing 13
Escalier Biosciences BV, Key Competitors 14
Escalier Biosciences BV, Key Employees 15
Escalier Biosciences BV, Subsidiaries 16

List of Figures
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Escalier Biosciences BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ASKA Pharmaceutical Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ASKA Pharmaceutical Co., Ltd. M …
  • CapitaLand Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CapitaLand Limited Mergers and …
  • SolarCity Corporation (SCTY):企業のM&A・提携動向(エネルギー分野)
    Summary SolarCity Corporation (SolarCity) is a service provider in the solar energy sector. The company provides solar power designing, financing, and installation, monitoring and clean energy services to homeowners, businesses, schools, non-profits and government organizations. SolarCity provides s …
  • Ricerca Biosciences, LLC(製薬・医療分野):企業M&A動向
    Summary Ricerca Biosciences, LLC (Ricerca) is a pharmaceutical company. The company offers a comprehensive, integrated suite of services to accelerate drug development. It combines nonclinical support for drug candidate selections with analytical and chemical development expertise to bring drug cand …
  • DHX Media Ltd.:企業の戦略・SWOT・財務分析
    SummaryDHX Media Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Analytik Jena AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Analytik Jena AG Mergers and Ac …
  • Blue Energy Limited (BUL):企業概要、財務及び戦略的SWOT分析
    Summary Blue Energy Limited (BEL) is an oil and gas exploration company. The company carries out exploration and production of coal seam gas and conventional oil and gas resources. Its projects include Bowen Basin, Carpentaria Basin, Cooperand Eromanga Basin, Galilee Basin, Maryborough Basin, South …
  • Pro-Pac Packaging Limited:企業のM&A・提携・投資分析
    Pro-Pac Packaging Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pro-Pac Packaging Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Mississippi Power Co:企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Iglo Foods Holdings Limited:企業の戦略・SWOT・財務分析
    SummaryIglo Foods Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Aksa Enerji Uretim AS (AKSEN):電力:M&Aディール及び事業提携情報
    Summary Aksa Enerji Uretim A.S. (Aksa Enerji), a subsidiary of Kazanci Holding A.S., is an independent power generation company. The company produces electricity through natural gas, fuel oil, hydro and wind power plants. Apart from power generation and sale, it also provides services such as projec …
  • Century Energy Ltd. (CEY.H):企業のM&A・提携動向(石油・ガス分野)
    Summary Century Energy Ltd. (Century) is an energy company that offers upstream services. The company operates through exploration and production of oil and gas. It has announced the signs property option agreement of a LOI to acquire interest in the St. Anthony and Best/King Bay mineral properties. …
  • Ferrovial, S.A. (formerly Grupo Ferrovial S.A.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ferrovial, S.A. (formerly Grupo …
  • University of Barcelona:企業のM&A・提携動向(医療分野)
    Summary University of Barcelona (UB) is an educational service provider that conducts research programs. The university offers bachelor’s degrees, master’s degrees and research doctoral studies. It provides EHEA bachelor's degree courses, pre-EHEA degree and university master's degree courses. UB al …
  • Federal Home Loan Bank of Chicago:企業の戦略・SWOT・財務分析
    SummaryFederal Home Loan Bank of Chicago - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務情報
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • KBC Group NV:企業の戦略・SWOT・財務分析
    SummaryKBC Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • CeraPedics Inc-医療機器分野:企業M&A・提携分析
    Summary CeraPedics Inc (Cerapedics) is a provider of osteobiologic treatment solutions. The company’s products include i-factor putty and i-factor flex. Its i-factor putty is a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to …
  • King’s College London:企業のM&A・提携動向(医療機器分野)
    Summary King's College London (KCL), a subsidiary of University of London is an educational institute that offers student services and graduate programs. The institute offers student services such as learning and teaching; modern language center, student services, library services, student news, stu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆